Evidence map›Paper›PMID 36936580›Full record

ArticleBMJ medicine2022

Changes in industry marketing payments to physicians during the covid-19 pandemic: quasi experimental, difference-in-difference study.

Kosuke Inoue, Jose F Figueroa, Naoki Kondo, Yusuke Tsugawa

Abstract read
In one paragraph

Article in BMJ medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Trends in Industry Payments to Cardiologists From 2014 to 2019.Circulation. Cardiovascular quality and outcomes · 2023
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kosuke InoueDepartment of Social Epidemiology, Kyoto University, Kyoto, Japan.ORCID 0000-0001-9614-8103
Jose F FigueroaDepartment of Health Policy and Management, Harvard School of Public Health, Harvard University, Cambridge, MA, USA.
Naoki KondoDepartment of Social Epidemiology, Kyoto University, Kyoto, Japan.
Yusuke TsugawaGeneral Internal Medicine and Health Services Research, UCLA, Los Angeles, CA, USA.ORCID 0000-0002-1937-4833

Funding

The Impact of Surgeon Factors and Education/Training on Disparities in Surgical Care.R01MD013913 · NIMHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TSUGAWA, YUSUKE · 2020 to 2024
$3.6M
The Impact of physician and health system factors on the quality of care for persons with Alzheimer's disease and related dementias at the end of lifeR01AG068633 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TSUGAWA, YUSUKE · 2020 to 2024
$3.0M
NIA NIH HHS R01 AG068633NIMHD NIH HHS R01 MD013913
6 · The paper itself

Abstract

Objective: To determine changes in industry marketing payments to physicians due to the covid-19 pandemic. Design: Quasi experimental, difference-in-difference study. Data source: US nationwide database of licensed physicians, the National Plan and Provider Enumeration System, which was linked to a database of industry marketing payments made to physicians, Open Payments. Population: All licensed US physicians from 2018 to 2020 and those who received payments from industry. Main outcome measures: Changes in the value and the number of monthly industry payments physician received before (January-February 2020) and during the pandemic (April-December 2020) were assessed, adjusting for physicians' characteristics (gender and specialty). As the control, data for the same months in 2019 were used. Industry payments by type of payments (eg, meals, travel, consulting fees, speaker compensation, honorariums), were also examined. Results: Among 880 589 US physicians included in this study, 267 463 (30.4%) physicians received a total of 4 117 482 non-research payments with $626 million ($710 per physician; £610; €708) in 2020 (40-44% decrease from $1047m in 2018 and $1115m in 2019). Industry payments decreased significantly in the months of the covid-19 pandemic (adjusted change in the value of -48.4%; 95% confidence interval -50.6 to -46.2; P<0.001; and adjusted change in the number of -47.4%, 95% confidence interval -47.7 to -47.1; P<0.001), particularly for meals and travel fees. No evidence was seen of a decrease in the number of industry payments for consulting and honorariums. A similar pattern was observed across physicians' gender and specialty. Conclusions: Industry payments to physicians, particularly those involving physical interactions such as meals and travel, substantially decreased during the pandemic. How such changes affect prescription practices and the quality of clinical practice in the long term should be investigated.

Indexed as

Health policy

Identifiers

PMID36936580
PMCPMC9978761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.